000 | 01125 a2200313 4500 | ||
---|---|---|---|
005 | 20250512081526.0 | ||
264 | 0 | _c19860328 | |
008 | 198603s 0 0 eng d | ||
022 | _a0271-0749 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAbernethy, D R | |
245 | 0 | 0 |
_aDoxepin-cimetidine interaction: increased doxepin bioavailability during cimetidine treatment. _h[electronic resource] |
260 |
_bJournal of clinical psychopharmacology _cFeb 1986 |
||
300 |
_a8-12 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAbsorption |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aBiological Availability |
650 | 0 | 4 |
_aCimetidine _xmetabolism |
650 | 0 | 4 |
_aDoxepin _xadministration & dosage |
650 | 0 | 4 | _aDrug Interactions |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aRandom Allocation |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aTodd, E L | |
773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 6 _gno. 1 _gp. 8-12 |
|
999 |
_c3955758 _d3955758 |